#NovoNordisk #GLP1Drugs #DrugSafety
www.aol.com
FDA: Novo Nordisk failed to report deaths of weight-loss drug patients
The manufacturer of popular weight-loss drugs Ozempic and Wegovy, Novo Nordisk, is taking heat from the federal government for regularly failing to report potential side effects of its GLP-1 medications, including deaths.
#ObesityTreatment #EyeHealth #GLP1Agonists
nypost.com
Which GLP-1 drug has the highest risk of sudden sight loss and 'eye...
The results of this obesity medication are literally eye-popping.
A new review of adverse effects reports to the FDA between the years 2017 and 2024 reveals that Ozempic and Wegovy have both been linked to dozens of cases of ischemic optic neuropathy (ION), or sudden vision loss caused by restricted blood flow to the optic nerve.
W
#WeightLossDrugs #HeartHealth #GLP1
nypost.com
Ozempic-style drugs could slash complication risks after heart...
A popular class of weight-loss drugs may prevent life-threatening cardiac complications by opening microscopic blood vessels that often remain blocked after a heart attack, according to a study published this week in Nature Communications.
#GLP1 #AddictionTreatment #WeightLossMedications
edition.cnn.com
Could popular weight loss drugs become the new treatment for addiction? Evidence is starting to mount
Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed answers through more study.
#GLP1drugs #Addiction #SubstanceUseDisorders
www.yahoo.com
What to know about how GLP-1 medications might fight addiction
Add Yahoo as a preferred source to see more of our stories on Google.
The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders -- and reduce the tragic outcomes they cause, a large new study finds.
#AddictionTreatment #GLP1 #MentalHealth
ca.style.yahoo.com
GLP-1 drugs may fight addiction across every major substance, according to a study of 600,000 people
Add Yahoo as a preferred source to see more of our stories on Google.
A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes.
#GLP1 #AddictionTreatment #WeightLossMedication
us.cnn.com
Could popular weight loss drugs become the new treatment for addiction? Evidence is starting to mount | CNN
Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed answers through more study.
#GLP1 #AddictionTreatment #SubstanceUseDisorder
apnews.com
What to know about how GLP-1 medications might fight addiction
The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders -- and reduce the tragic outcomes they cause, a large new study finds.
#GLP1 #Semaglutide #HealthImpact
nypost.com
A hidden ingredient in the new Ozempic and Wegovy pills may have...
The new pill form of popular GLP-1 drugs contains a compound that could cause troubling side effects.
Historically, semaglutide, the active ingredient in Ozempic and Wegovy, has been administered via weekly injections into the fatty tissue just under the skin of the stomach, thigh or upper arm.
#HealthRisks #Osteoporosis #GLP1Drugs
ca.style.yahoo.com
GLP-1 weight loss drugs could increase risk of osteoporosis and gout, new research finds
Add Yahoo as a preferred source to see more of our stories on Google.
Taking popular GLP-1 class weight loss drugs like Ozempic and Wegovy could be linked to a higher risk of developing osteoporosis, gout and a condition that causes severe bone softening compared to people who don't use the medications, researchers said Monday.
#GLP1 #Osteoporosis #WeightLoss
nypost.com
Drugs like Ozempic can increase your risk of a silent but serious...
The benefits of GLP-1 drugs like Ozempic are myriad, from weight loss to improved cardiovascular health to potentially preventing dementia, lowering the risk of depression, and reducing the intensity of migraines.
H
#CardiovascularHealth #ObesityManagement #GLP1
health.usnews.com
GLP-1 Drugs for Heart Health: Benefits, Side Effects & Who Should Take Them
Cardiologists and obesity medicine physicians alike are hopeful about these preliminary findings. However, lifestyle habits, including getting adequate sleep, eating healthy and exercising, are still the top ways to stave off cardiovascular disease.
#GLP1 #WeightLoss #DiabetesManagement
www.businessinsider.com
Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.
The pill, which analysts say might cost $300 a month, could be available as soon as mid-2026.
Better injections and better pills.
#GLP1 #WeightLoss #SexualHealth
nypost.com
Exclusive | We lost weight on GLP-1 drugs -- and then we lost our sex drives
Welcome to The Thin Line, The New York Post's series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage diabetes and improve other health conditions, they are not without risks.
#WeightLoss #DiabetesTreatment #GLP1
nypost.com
People dropped out of Eli Lilly's new GLP-1 drug trial because they...
Participants taking the highest dose of Eli Lilly's new GLP-1 drug lost an average of 28. 7% of their body weight in a late-stage trial, putting it on track to be a heavyweight in the crowded world of weight-loss and diabetes treatments.
